Aasia Kalsoom | Development of New Vaccines | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Aasia Kalsoom – Pakistan Council of Scientific and Industrial Research – Pakistan

Aasia Kalsoom
Affiliation Pakistan Council of Scientific and Industrial Research
Country Pakistan
Scopus ID 57204200924
Documents 8
Citations 56
h-index 4
Subject Area Development of New Vaccines
Event International Research Awards on Infectious Diseases

The Innovative Research Award is a research recognition category associated with the International Research Awards on Infectious Diseases. This article presents the supplied bibliographic profile of Aasia Kalsoom, affiliated with the Pakistan Council of Scientific and Industrial Research in Pakistan, with a stated subject area of development of new vaccines. The profile includes publication and citation indicators attributed to the researcher’s supplied Scopus author record. These metrics provide a quantitative overview of indexed scholarly output but do not, on their own, establish the novelty, quality, or clinical impact of individual research contributions. [1]

Abstract

This article outlines the available research-profile information for Aasia Kalsoom, whose stated institutional affiliation is the Pakistan Council of Scientific and Industrial Research. The supplied Scopus profile identifies eight documents, 56 citations, and an h-index of 4. The stated subject area is the development of new vaccines, a field relevant to infectious disease prevention, immunology, antigen research, and vaccine development. The article discusses the significance and limitations of these indicators in the context of research recognition. Specific publications, experimental findings, author contributions, and independently verified award decisions have not been supplied and are therefore not asserted here. [1] [2]

Keywords

Aasia Kalsoom; Innovative Research Award; Pakistan Council of Scientific and Industrial Research; Pakistan; development of new vaccines; infectious diseases; vaccine research; scientific publications; citation analysis; research impact; Scopus author profile; biomedical research.

Introduction

Vaccine development is an important component of infectious disease research. It involves the identification of protective antigens, evaluation of immune responses, assessment of safety, and investigation of strategies that can prevent or reduce the burden of infectious diseases. Research in this area can involve microbiology, immunology, molecular biology, biotechnology, clinical investigation, and public health. The translation of laboratory findings into effective vaccines requires evidence from appropriate experimental and clinical studies. [2] [3]

Research Profile

Aasia Kalsoom is associated in the supplied information with the Pakistan Council of Scientific and Industrial Research in Pakistan. The stated subject area is development of new vaccines. The Scopus author identifier provided for this profile is 57204200924. The profile can be consulted through the publisher’s author-detail page to examine indexed records and associated bibliographic information. [1]

Research Contributions

The supplied subject area places the research profile within the broad field of new vaccine development. Vaccine research can address scientific questions about pathogen biology, antigen selection, immune recognition, immunogenicity, protective efficacy, safety, and implementation. The specific contribution of an individual researcher must, however, be established from publications, project records, documented author roles, and relevant experimental or clinical evidence. [2] [3]

Publications

The supplied bibliometric information lists eight documents associated with the Scopus author identifier 57204200924. A publication-by-publication inventory has not been provided for this article. The linked Scopus author page is the appropriate starting point for verifying document titles, author lists, source titles, publication dates, citation records, and available digital object identifiers. [1]

Research Impact

The supplied profile reports 56 citations across eight documents and an h-index of 4. These indicators describe aspects of the recorded scholarly attention associated with the profile. Citation counts can help identify research outputs that have been referenced by later publications, while the h-index combines publication productivity and citation frequency into a single measure. Neither measure directly evaluates methodological quality, originality, clinical usefulness, or the accuracy of research findings. [1] [3]

Award Suitability

The Innovative Research Award is associated here with the International Research Awards on Infectious Diseases. The supplied institutional affiliation, stated vaccine-development subject area, and bibliometric profile provide contextual information that may be relevant when considering research in the infectious diseases field. The available data alone do not establish eligibility, nomination status, selection, or receipt of the award.[1]

Conclusion

Aasia Kalsoom’s supplied research profile identifies an affiliation with the Pakistan Council of Scientific and Industrial Research in Pakistan and a subject area of development of new vaccines. The provided Scopus indicators comprise eight documents, 56 citations, and an h-index of 4. These figures offer a limited quantitative description of indexed research activity. A fuller scholarly assessment would require verification of the author record, examination of individual publications, and evidence of specific contributions to vaccine or infectious diseases research. Award eligibility and recognition should be established through the official program and its documented evaluation process.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Aasia Kalsoom, Author ID 57204200924. Scopus. Author-profile metrics and document records should be checked against the current database entry.
    https://www.scopus.com/authid/detail.uri?authorId=57204200924
  2. Rasool, M., Malik, A., Waquar, S., Tul-Ain, Q., Jafar, T. H., Rasool, R., & Kalsoom, A. (n.d.). In-silico characterization and in-vivo validation of Albiziasaponin-A, iso-orientin, and salvadorin using a rat model of Alzheimer’s disease.
    https://pubmed.ncbi.nlm.nih.gov/30123124/
  3. Kalsoom, A., Abidi, S. H., Marwat, S. A., Shabbir, G., Naveed, M., & Mughal, A. M. A. (n.d.). Immunopharmacological and structural design of a polyprotein-based multi-epitope vaccine against Powassan virus.
    https://link.springer.com/article/10.1007/s00210-026-05519-y

Prof. huakun lv | Infectious Diseases Vaccines | Best Researcher Award

Posted on by International Research Awards on Infectious Diseases

Prof. huakun lv | Infectious Diseases Vaccines | Best Researcher Award

Zhejiang Provincial Center for Disease Control and Prevention | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Huakun Lv earned his Master of Science in Epidemiology and Health Statistics from the School of Public Health, Southeast University, Nanjing, in 2005. Prior to that, he completed his Bachelor of Science in Preventive Medicine at the same institution in 1992. His academic journey laid a strong foundation in public health, epidemiology, and disease prevention, equipping him with the expertise to address complex health challenges and lead immunization initiatives.

💼PROFESSIONAL ENDEAVORS

Dr. Lv, Chief Physician and Director of the Immunization Program at Zhejiang CDC, has been a driving force in vaccine strategies, coverage, and disease prevention since 2014. Previously, as Deputy Director of Infectious Disease Control and Prevention (2005–2014), he played a pivotal role in infectious disease surveillance, building on his frontline public health experience at Danyang CDC, Jiangsu Province (1992–2002). Beyond his institutional leadership, he has made significant global health contributions, serving as an Epidemiologist in the Chinese Government Emergency Medical Team in the Philippines (2013) during the Typhoon Haiyan response and as Deputy Director of the Zhejiang Public Health and Medical Team in Qingchuan, Sichuan Province (2008) after the Sichuan Earthquake. His expertise in applied epidemiology was further strengthened as a Visiting Scholar at Emory University’s School of Public Health (2011).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASE VACCINES

Dr. Lv’s research primarily focuses on epidemiology and the prevention of vaccine-preventable diseases. His work encompasses immunization program policies, the effectiveness of vaccination strategies, and the epidemiology and virology of Hand, Foot, and Mouth Disease (HFMD). He has also conducted significant studies on biofilm resistance and endoscopic disinfection practices, contributing to the broader understanding of infection control. His involvement in vaccine clinical trials and public health interventions has played a crucial role in shaping vaccine policies and improving disease prevention measures.

🌍IMPACT AND INFLUENCE

Dr. Lv’s impact on public health extends beyond Zhejiang Province, as he has been at the forefront of immunization initiatives that have improved vaccine accessibility and effectiveness. His expertise in epidemiology has led to substantial contributions in global disease control efforts. His involvement in emergency medical responses and his advisory roles in infectious disease management have positioned him as a key figure in international public health collaborations.

📚ACADEMIC CITATIONS

Dr. Lv’s research has been widely recognized and cited in scientific publications. Notable among his achievements is his study on the Epidemiological and Etiological Characteristics of HFMD in Zhejiang Province, which earned him a Second Prize Award. Additionally, his research on the Effect of Endoscopic Cleaning and Disinfection on Biofilm received a Third Prize Award. His publications have contributed significantly to the understanding of infectious disease epidemiology and vaccine effectiveness, influencing public health policies and practices.

🏆RESEARCH GRANTS AND FUNDING

Dr. Lv has successfully secured multiple research grants for immunization and epidemiology projects. His funding contributions have supported vaccine clinical trials, public health surveillance initiatives, and innovative disease prevention strategies. These grants have facilitated critical research aimed at enhancing vaccination programs and improving disease control efforts at both national and international levels.

🦠LEGACY AND FUTURE CONTRIBUTIONS

With a commitment to mentoring the next generation of epidemiologists and public health professionals, Dr. Lv continues to play an active role in academia and research. His dedication to advancing vaccine research, implementing effective immunization policies, and fostering global collaborations in infectious disease prevention underscores his lasting impact on public health. His vision is to continue developing innovative strategies that address emerging infectious diseases and strengthen global health security.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lv holds several prestigious positions in professional organizations. He serves as Vice-Chairman of the Division of Immunology at the Zhejiang Preventive Association and is a Master Supervisor at the School of Public Health, Xiamen University. He is also a Field Tutor for the Chinese Field Epidemiology Training Program (CFETP) at the Chinese CDC and a Research Supervisor at the Chinese Hepatitis Prevention and Treatment Foundation. Additionally, he is a Standing Committee Member of the Division of Vaccine Clinical Trials at the China Association for Vaccines (CAV). His leadership in these roles reflects his commitment to advancing infectious disease research, vaccine development, and public health policy.

📑NOTABLE PUBLICATIONS

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens

Authors: H. Lv, Huakun; X. Chen, Xu; B. Xing, Bo; Z. Liang, Zhenzhen; Y. Mao, Yu
Year: 2025
Journal: Scientific Reports

Immunogenicity and safety of live attenuated influenza vaccine in children aged 3–17 years in China

Authors: L. Ai, Lizhe; Z. Gao, Zhao; H. Lv, Huakun; D. Liu, Dawei; Q. Yu, Qiong
Year: 2025
Journal: Vaccine

Validation of a questionnaire for evaluating vaccine literacy in adulthood vaccination: A pilot study from Zhejiang province, China

Authors: X. Luo, Xiaofu; J. Shen, Jianyong; H. Lv, Huakun; Y. Hu, Yu
Year: 2025
Journal: Human Vaccines and Immunotherapeutics

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

Authors: Z. Liang, Zhenzhen; X. Chen, Xu; B. Xing, Bo; H. Lv, Huakun; Y. Mao, Yu
Year: 2024
Journal: Frontiers in Immunology

Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China

Authors: H. Zhang, Hangjie; Q. Hua, Qianhui; J. Jiang, Jianmin; H. Lv, Huakun
Year: 2023
Journal: eLife